Recent Quotes (30 days)

You have no recent quotes
chg | %

biOasis Technologies Inc  

(Public, CVE:BTI)   Watch this stock  
Find more results for BTI
0.00 (0.00%)
Delayed:   9:54AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.02 - 1.06
52 week 0.66 - 2.05
Open 1.05
Vol / Avg. 17,528.00/57,283.00
Mkt cap 51.07M
P/E     -
Div/yield     -
EPS -0.07
Shares 45.65M
Beta 1.24
Inst. own     -

Key stats and ratios

Q4 (Nov '16) 2016
Net profit margin -453.42% -697.04%
Operating margin -449.95% -695.12%
EBITD margin - -680.73%
Return on average assets -170.73% -117.90%
Return on average equity -295.99% -138.17%
CDP Score - -


130-10691 Shellbridge Way
+1-604-6334446 (Phone)
+1-604-2788785 (Fax)

Website links


biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.

Officers and directors

Robin B. Hutchison Executive Chairman of the Board
Age: 59
Mark Day Ph.D. President, Chief Executive Officer, Director
Judi Dalling Chief Financial Officer, Corporate Secretary
Ronald P. Erickson Independent Director
Age: 72
H. Christian Fibiger P.hD. Independent Director
Age: 71
Greg D. Gubitz Independent Director
Age: 57
J. Michael Hutchison QC Independent Director
Age: 70
Terry Pearson Ph.D. Independent Director
Age: 69